
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>2025 Best of Systematic Reviews and Meta-Analyses in Gastrointestinal Endoscopy</title>
<style>

<style>
/* ===== GENERAL LAYOUT ===== */
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #eef2ff, #fafafa);
    color: #2c2c2c;
    padding: 30px;
    margin: 0;
}

/* Centered mindmap container */
.mindmap {
    max-width: 800px;
    margin: auto;
    font-size: 20px;
    line-height: 1.7;
}

/* ===== LISTS ===== */
.mindmap ul {
    margin: 0.6em 0 1em 1.5em;
    padding-left: 1.4em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #8b5cf6; /* accent bullet color */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}

/* ===== COLLAPSIBLE SECTIONS ===== */
.mindmap details {
    /* FIX: Increased border width and used a darker color */
    border-left: 5px solid #7c3aed; 
    background: #ffffff;
    margin: 8px 0;
    /* FIX: Corrected typo "20x" to "20px" */
    padding: 9px 25px; 
    border-radius: 20px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.1);
    transition: all 0.3s ease;
    position: relative;
}

/* Subsection (nested details) */
.mindmap details > div > details {
    margin-left: -8px;
    /* FIX: Used a darker, more saturated color for the nested border */
    border-color: #9333ea; 
    background: #faf7ff;
}

/* Subtle hover feedback */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.18);
    background: linear-gradient(135deg, #ffffff, #f5f0ff);
}

/* ===== SUMMARY HEADERS ===== */
.mindmap summary {
    cursor: pointer;
    font-size: 1.1em;
    font-weight: 600;
    list-style: none;
    position: relative;
    /* FIX: Increased padding slightly to prevent text from touching the arrow icon */
    padding-left: 24px; 
    color: #4c1d95;
    outline: none;
}

/* Custom arrow icon */
.mindmap summary::before {
    content: "‚ñ∂";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

/* Rotated arrow when open */
.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Section title emphasis */
.mindmap summary strong {
    display: block;
    font-size: 1.25em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Open section highlighting */
.mindmap details[open] > summary {
    background: #f3e8ff;
    border-radius: 8px;
    padding: 6px 10px;
}

/* Smooth fade for expanded content */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* ===== DESCRIPTION BOXES ===== */
.mindmap .desc-box {
    background: #fdfcff;
    border: 2px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 6px 10px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.05);
    transition: background 0.3s ease;
}
.mindmap .desc-box:hover {
    background: #f8f4ff;
}

/* ===== ANIMATIONS ===== */
@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}

/* ===== BUTTONS ===== */
button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
button:hover {
    background-color: #6b21a8;
    transform: scale(1.05);
}

/* ===== FLOATING CONTROL PANEL ===== */
#level-controls {
    position: fixed;
    bottom: 30px;
    left: 85%;
    transform: translateX(-50%);
    background: rgba(255, 255, 255, 0.05);
    padding: 10px 16px;
    border-radius: 12px;
    box-shadow: 0 4px 12px rgba(0, 0, 0, 0.15);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move;
    display: flex;
    align-items: center;
    gap: 6px;
}

/* Buttons inside the panel */
#level-controls button {
    background-color: rgba(124, 58, 237, 0.85);
    color: white;
    border: none;
    padding: 8px 14px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.95);
    transform: scale(1.05);
}

/* Search input inside panel */
#level-controls input {
    border: 1px solid #d5c4ff;
    border-radius: 8px;
    padding: 7px 10px;
    font-size: 0.95em;
    outline: none;
    width: 150px;
    transition: border-color 0.2s ease;
}
#level-controls input:focus {
    border-color: #8b5cf6;
}

/* Search count text */
#searchCount {
    margin-left: 8px;
    font-style: italic;
    color: #4c1d95;
    font-size: 0.9em;
}

/* ===== SEARCH HIGHLIGHT ===== */
mark.search-highlight {
    background-color: #fff59d;
    color: #000;
    border-radius: 3px;
    padding: 1px 3px;
}



/* ===== CLICK-TO-REVEAL: Spoiler Blur Style ===== */
.mindmap q {
    cursor: pointer;
    color: transparent;
    /* Apply a text-shadow with the same color as the text to create the blur effect */
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease;
}

.mindmap q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* Style for the revealed text */
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}




/*for full control button*/
/* ===== CLICK-TO-REVEAL: Spoiler Blur Style (with Read Mode) ===== */

/* This rule applies the blur ONLY when the mindmap is NOT in read-mode. */
.mindmap:not(.read-mode) q {
    cursor: pointer;
    color: transparent;
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease, color 0.3s ease;
}

.mindmap:not(.read-mode) q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* This combined rule handles BOTH cases for revealing text:
   1. The entire mindmap is in read-mode.
   2. An individual <q> has been clicked (in quiz mode).
*/
.mindmap.read-mode q,
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}


</style>

</style>
</head>
<body>

<!-- Updated Controls -->
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="zoomIn()">+</button>
    <button onclick="zoomOut()">-</button>
    <button onclick="resetView()">=</button>
    <!-- NEW: READ MODE TOGGLE BUTTON -->
    <button onclick="toggleReadMode()">Q/R</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>2025 Best of Systematic Reviews and Meta-Analyses in Gastrointestinal Endoscopy</strong></summary>
            <div>
                <ul><li>- Author: Babu P. Mohan, MD</li><li>- Journal: GASTROINTESTINAL ENDOSCOPY</li><li>- Publication: Volume 102, No. 5 : 2025</li></ul>
                
        <details>
            <summary><strong>üí° Knowledge Test</strong></summary>
            <div>
                <ul><li>- What is the odds ratio for <b>aborted procedures</b> in patients on GLP-1RAs compared to controls?</li><li>- In malignancy-related GI bleeding, hemostatic powder monotherapy improves the initial hemostasis rate by what risk ratio compared to conventional therapy?</li><li>- What is the pooled eradication rate for GAVE when using <b>EBL</b> vs. <b>APC</b>?</li><li>- Which endoscopic antireflux therapy, <b>ARMS</b> or <b>Stretta</b>, has a significantly higher risk of stricture, and by what odds ratio?</li><li>- In patients with ulcerative colitis, <b>Dye-based chromoendoscopy (DCE)</b> was found to be superior to which other screening technology for dysplasia detection?</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>üíä Effects of GLP-1 Receptor Agonists (GLP-1RAs) in GI and Endoscopy</strong></summary>
            <div>
                <ul><li>- Multiple meta-analyses highlight significant effects of GLP-1RAs on endoscopy outcomes and GI adverse events.</li></ul>
                
        <details>
            <summary><strong>Endoscopy Outcomes (Singh et al.)</strong></summary>
            <div>
                <ul><li>- Analysis of 23 studies involving 77,152 patients (4,449 on GLP-1RA).</li></ul>
                
        <details>
            <summary><strong>‚¨ÜÔ∏è Increased Risk Events</strong></summary>
            <div>
                <ul><li>- Patients on GLP-1RAs demonstrated significantly higher odds of:</li></ul>
                
        <details>
            <summary><strong>Retained Gastric Contents</strong></summary>
            <div>
                <ul><li>- OR: <q><b>15.39</b></q> (P < .01).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Aborted Procedures</strong></summary>
            <div>
                <ul><li>- OR: <q><b>13.86</b></q> (P < .01).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>üö´ No Significant Difference</strong></summary>
            <div>
                <ul><li>- Despite increased gastric contents, there was no significant difference in:</li></ul>
                
        <details>
            <summary><strong>Aspiration Events</strong></summary>
            <div>
                <ul><li>- OR: 21.06 (P = .24).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Bowel Preparation Quality</strong></summary>
            <div>
                <ul><li>- Subjective assessment showed no difference (OR: <q>0.94</q>).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Upper GI Endoscopy Specifics (Baig et al.)</strong></summary>
            <div>
                <ul><li>- Findings were similar to the Singh et al. analysis.</li></ul>
                
        <details>
            <summary><strong>‚¨áÔ∏è Reduced Retained Contents</strong></summary>
            <div>
                <ul><li>- A significant reduction in retained gastric contents was observed when upper endoscopy and colonoscopy were performed on the <u>same day</u> versus upper endoscopy alone.</li><li>- OR: <q><b>0.28</b></q> (P < .001).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Adverse GI Events (Chiang et al.)</strong></summary>
            <div>
                <ul><li>- Meta-analysis of 55 randomized controlled trials (106,395 participants).</li></ul>
                
        <details>
            <summary><strong>Increased Risk vs. Placebo</strong></summary>
            <div>
                <ul><li>- GLP-1RAs increased the risk of:</li></ul>
                
        <details>
            <summary><strong>Cholelithiasis</strong></summary>
            <div>
                <ul><li>- RR: <q><b>1.46</b></q> (1.09-1.97).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>GERD</strong></summary>
            <div>
                <ul><li>- RR: <q><b>2.19</b></q> (1.48-3.25).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Subgroup Analysis</strong></summary>
            <div>
                <ul><li>- Effects were more pronounced in trials with:</li><li>- Individuals with <b>obesity</b> or <b>steatotic liver disease</b>.</li><li>- Use of <b>weight-loss-inducing</b> GLP-1RAs.</li><li>- <b>High-dose</b> formulations.</li><li>- <u>Note:</u> These subgroup effects were not statistically significant.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>ü©∏ Endoscopic Band Ligation (EBL) in Gastric Antral Vascular Ectasia (GAVE)</strong></summary>
            <div>
                <ul><li>- A meta-analysis by Garg et al. compared EBL with the more widely used Argon Plasma Coagulation (APC).</li></ul>
                
        <details>
            <summary><strong>EBL vs. APC: Key Outcomes</strong></summary>
            <div>
                <ul><li>- Analysis of 10 studies with 476 subjects.</li><li>- Overall results were <u>overwhelmingly in support of EBL</u>.</li></ul>
                
        <details>
            <summary><strong>‚úÖ Superior Efficacy of EBL</strong></summary>
            <div>
                <ul><li>- <b>Eradication Rate:</b> EBL <q><b>88.6%</b></q> vs. APC <q><b>57.9%</b></q> (RR 1.52, P < .001).</li><li>- <b>Bleeding Recurrence:</b> EBL <q><b>6.6%</b></q> vs. APC <q><b>39.7%</b></q>.</li><li>- <b>GAVE Recurrence:</b> EBL <q><b>7.3%</b></q> vs. APC <q><b>38.5%</b></q>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>‚¨áÔ∏è Improved Clinical Metrics with EBL</strong></summary>
            <div>
                <ul><li>- <u>Fewer treatment sessions</u> required with EBL.</li><li>- <u>Lower transfusion requirements</u> with EBL.</li><li>- <u>Fewer hospitalizations</u> with EBL.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>‚ö†Ô∏è Adverse Events</strong></summary>
            <div>
                <ul><li>- Adverse event rate was higher with EBL, but none were considered 'reportable' by ASGE lexicon.</li><li>- EBL: <q><b>16.8%</b></q></li><li>- APC: <q><b>9.3%</b></q></li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Limitations</strong></summary>
            <div>
                <ul><li>- A major limitation was the inclusion of observational retrospective studies.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>üí® Hemostatic Powder in Nonvariceal GI Bleeding</strong></summary>
            <div>
                <ul><li>- Liu et al. evaluated the efficacy of hemostatic powders versus conventional endoscopic therapy (CET).</li></ul>
                
        <details>
            <summary><strong>Efficacy based on Bleeding Etiology</strong></summary>
            <div>
                <ul><li>- Meta-analysis of 8 studies (653 patients).</li></ul>
                
        <details>
            <summary><strong>Malignancy-Related Bleeding</strong></summary>
            <div>
                <ul><li>- Hemostatic powder monotherapy was <u>significantly superior</u> to CET.</li></ul>
                
        <details>
            <summary><strong>Initial Hemostasis</strong></summary>
            <div>
                <ul><li>- Improved rate with RR <q><b>1.5</b></q> (1.28-1.75).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>30-Day Recurrent Bleeding</strong></summary>
            <div>
                <ul><li>- Reduced rate with RR <q><b>0.32</b></q> (0.12-0.86).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Non-Malignant Bleeding</strong></summary>
            <div>
                <ul><li>- Hemostatic powders demonstrated <u>similar outcomes</u> to CET for:</li><li>- Initial hemostasis.</li><li>- 30-day recurrent bleeding rates.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Trial Sequential Analysis</strong></summary>
            <div>
                <ul><li>- Confirmed the robust results for <b>malignancy-related</b> causes.</li><li>- Concluded that the relative efficacy in <b>non-malignant</b> bleeding remains <u>unresolved</u>.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>üî• Endoscopic Antireflux Therapy for GERD</strong></summary>
            <div>
                <ul><li>- Angeramo et al. compared Anti-Reflux Mucosectomy (ARMS) vs. Radiofrequency Ablation (Stretta procedure).</li></ul>
                
        <details>
            <summary><strong>ARMS vs. Stretta: Efficacy & Safety</strong></summary>
            <div>
                <ul><li>- Systematic review of 66 studies (3,767 patients).</li><li>- Stretta group (n=3074) was much larger than ARMS group (n=693).</li></ul>
                
        <details>
            <summary><strong>‚úÖ Clinical Efficacy: Similar Outcomes</strong></summary>
            <div>
                <ul><li>- Both modalities demonstrated similar effectiveness.</li></ul>
                
        <details>
            <summary><strong>Patient Satisfaction</strong></summary>
            <div>
                <ul><li>- ARMS: <q><b>77%</b></q></li><li>- Stretta: <q><b>65%</b></q></li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Reduced PPI Use</strong></summary>
            <div>
                <ul><li>- ARMS: Reduction from <q>99% to 48%</q>.</li><li>- Stretta: Reduction from <q>100% to 40%</q>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>GERD-HRQL Scores</strong></summary>
            <div>
                <ul><li>- Both showed significant improvement.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>‚ö†Ô∏è Safety Profile: Stretta is Safer</strong></summary>
            <div>
                <ul><li>- <u>ARMS demonstrated greater overall morbidity</u>: <q><b>25%</b></q> vs. <q><b>17%</b></q> for Stretta (P < .001).</li></ul>
                
        <details>
            <summary><strong>Risk of Stricture</strong></summary>
            <div>
                <ul><li>- Significantly greater with ARMS.</li><li>- OR: <q><b>13.03</b></q>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Risk of Bleeding</strong></summary>
            <div>
                <ul><li>- Significantly greater with ARMS.</li><li>- OR: <q><b>13.16</b></q>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Risk of Perforation</strong></summary>
            <div>
                <ul><li>- Significantly greater with ARMS.</li><li>- OR: <q><b>13.03</b></q>.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Limitations & Considerations</strong></summary>
            <div>
                <ul><li>- Primarily retrospective cohort studies.</li><li>- Grossly unequal sample sizes.</li><li>- ARMS is a newer procedure with an <u>unknown learning curve</u>.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>üî¨ Endoscopy in Inflammatory Bowel Disease (IBD)</strong></summary>
            <div>
                <ul><li>- Shehab et al. performed a network meta-analysis on endoscopic dysplasia detection technologies.</li></ul>
                
        <details>
            <summary><strong>Comparison of Dysplasia Detection Technologies</strong></summary>
            <div>
                <ul><li>- Analysis of 25 studies (4,837 patients, 850 dysplastic lesions).</li></ul>
                
        <details>
            <summary><strong>üèÜ Top Performer: Dye-Based Chromoendoscopy (DCE)</strong></summary>
            <div>
                <ul><li>- In per-lesion analysis, <b>DCE</b> ranked highest (<q><b>83%</b></q>).</li></ul>
                
        <details>
            <summary><strong>DCE vs. HD-WLE</strong></summary>
            <div>
                <ul><li>- DCE was <u>superior</u> to high-definition white-light endoscopy.</li><li>- OR: <q><b>1.78</b></q> (1.06-3).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>DCE vs. Other Advanced Techniques</strong></summary>
            <div>
                <ul><li>- <u>No significant differences</u> were found in head-to-head comparisons with:</li><li>- Narrow-band imaging (NBI).</li><li>- HD-WLE with segmental reinspection.</li><li>- Chromoendoscopy-guided endomicroscopy.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Subgroup: Ulcerative Colitis</strong></summary>
            <div>
                <ul><li>- DCE again ranked highest in per-lesion analysis.</li></ul>
                
        <details>
            <summary><strong>DCE vs. NBI</strong></summary>
            <div>
                <ul><li>- DCE was <u>superior</u> to narrow-band imaging in this subgroup.</li><li>- OR: <q><b>1.69</b></q> (1.03-2.77).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Noteworthy Technique: HD-WLE with Segmental Reinspection</strong></summary>
            <div>
                <ul><li>- Showed interesting utility, but this finding stemmed from only <u>one study</u> performed at expert centers.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
    </div>
    
</div>

<br>
<br>
<br>
<br>
<br>


<script>
// --- State Management for Expansion Level ---
let currentLevel = 1; 
const maxLevel = 10;
const minLevel = 1;

// --- Core Function to Set Mindmap Expansion ---
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');
    allDetails.forEach(detail => detail.removeAttribute('open'));
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') {
                depth++;
            }
            parent = parent.parentElement;
        }
        if (depth < level) {
            detail.setAttribute('open', '');
        }
    });
}

// --- Control Functions ---
function zoomIn() {
    if (currentLevel < maxLevel) {
        currentLevel++;
        setMindmapLevel(currentLevel);
    }
}

function zoomOut() {
    if (currentLevel > minLevel) {
        currentLevel--;
        setMindmapLevel(currentLevel);
    }
}

function resetView() {
    currentLevel = minLevel;
    setMindmapLevel(currentLevel);
}


// --- NEW: Function to Toggle Read/Quiz Mode ---
function toggleReadMode() {
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.classList.toggle('read-mode');
    }
}

// --- Draggable Controls ---
function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;
    const onMouseDown = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };
    const elementDrag = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none";
        elmnt.style.bottom = "auto";
    };
    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };
    if (document.getElementById(elmnt.id)) {
        document.getElementById(elmnt.id).onmousedown = onMouseDown;
    } else {
        elmnt.onmousedown = onMouseDown;
    }
}




// --- Initial Setup ---
window.addEventListener('DOMContentLoaded', () => {
    // Set the initial mindmap view
    setMindmapLevel(currentLevel);

    // Get the draggable controls element
    const controls = document.getElementById('level-controls');
    if (controls) {
        dragElement(controls);
    }

    // --- CORRECTED & IMPROVED: Setup for Click-to-Reveal ---
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.addEventListener('click', function(event) {
            // Use .closest() to find the nearest parent <q> tag.
            // This is more robust than checking event.target.tagName.
            const quoteElement = event.target.closest('q');
            
            if (quoteElement) {
                // Add the 'is-revealed' class to show the text
                quoteElement.classList.add('is-revealed');
            }
        });
    }
});
</script>

</body>
</html>
